Sirnaomics Ltd (2257)

Currency in HKD
7.88
-0.42(-5.06%)
Closed·
2257 Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
Unusual trading volume
Fair Value
Day's Range
7.598.35
52 wk Range
2.358.58
Key Statistics
Bid/Ask
7.88 / 7.88
Prev. Close
8.3
Open
8.3
Day's Range
7.59-8.35
52 wk Range
2.35-8.58
Volume
1.29M
Average Volume (3m)
528.29K
1-Year Change
89.93%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2257 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
72.14
Upside
+815.42%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Sirnaomics Ltd News & Analysis

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy

Sirnaomics Ltd Company Profile

Sirnaomics Ltd., an RNA therapeutics biopharmaceutical company, discovers and develops drugs for indications with medical needs. The company’s therapeutics products focus on oncology and fibrosis, anticoagulant therapies, cardiometabolic disease, complement-mediated diseases, medical aesthetics, and viral infections. Its lead drug candidates include STP705 for the treatment of non-melanoma skin cancer and for focal fat reduction; and STP707 to treat solid tumors. The company is also developing STP122G for the treatment of coagulation disorders; STP125G to treat hypertriglyceridemia; and STP144G for the treatment of complement diseases. In addition, it is developing STP247G to treat complement-mediated immunologic diseases; STP237G for the treatment of hypertension in combination with familial hypertriglyceridemia; and STP136G to treat hypertension. The company was founded in 2007 and is based in Wan Chai, Hong Kong.

Compare 2257 to Peers and Sector

Metrics to compare
2257
Peers
Sector
Relationship
P/E Ratio
−2.1x−2.2x−0.5x
PEG Ratio
−0.06−0.110.00
Price/Book
−65.7x1.7x2.6x
Price / LTM Sales
62.1x12.5x3.2x
Upside (Analyst Target)
-199.8%42.0%
Fair Value Upside
Unlock32.7%6.6%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 72.14
(+815.42% Upside)

Earnings

Latest Release
Apr 25, 2025
EPS / Forecast
-0.13 / --
Revenue / Forecast
868.00K / --
EPS Revisions
Last 90 days

2257 Income Statement

FAQ

What Stock Exchange Does Sirnaomics Trade On?

Sirnaomics is listed and trades on the Hong Kong Stock Exchange stock exchange.

What Is the Stock Symbol for Sirnaomics?

The stock symbol for Sirnaomics is "2257."

What Is the Sirnaomics Market Cap?

As of today, Sirnaomics market cap is 866.05M.

What Is Sirnaomics's Earnings Per Share (TTM)?

The Sirnaomics EPS (TTM) is -0.66.

From a Technical Analysis Perspective, Is 2257 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Sirnaomics Stock Split?

Sirnaomics has split 0 times.

How Many Employees Does Sirnaomics Have?

Sirnaomics has 69 employees.

What is the current trading status of Sirnaomics (2257)?

As of 30 Jul 2025, Sirnaomics (2257) is trading at a price of 7.88, with a previous close of 8.30. The stock has fluctuated within a day range of 7.59 to 8.35, while its 52-week range spans from 2.35 to 8.58.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.